Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02887391
Other study ID # E-2358
Secondary ID
Status Enrolling by invitation
Phase N/A
First received August 15, 2016
Last updated August 29, 2016
Start date January 2016
Est. completion date June 2017

Study information

Verified date August 2016
Source University of Calgary
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

Although hemodialysis is life-saving, unfortunately, people on dialysis often have declining health, quality of life as well as poor nutritional status. Hemodialysis patients must follow a very restrictive diet, and many patients do not eat well and usually report poor appetites. A new approach to dialysis is being used in some hospitals in Alberta and elsewhere, called in-centre nocturnal hemodialysis. This in-centre nocturnal dialysis allows people to receive their dialysis at a hospital or clinic while they sleep. Since this in-centre nocturnal dialysis gives people 8-hour hemodialysis treatment 3 times per week (24 hours of dialysis per week) the patients have better removal of the waste products from their bodies than conventional hemodialysis (an average of 12 hours per week). Also of importance, when using in-centre nocturnal dialysis, people will have more time during the day to work, spend with family, as well as have time to shop for food, to cook and even to eat, which in turn will likely result in improvement in the quality of their lives. This study will follow 10 patients on conventional dialysis and 10 patients on in-centre nocturnal dialysis for 6 months and compare their food intake, muscle mass, weight, body mass index (BMI) and nutrition-related lab tests. The purpose of this study is to determine whether there is an improvement in the nutritional status of the in-centre nocturnal hemodialysis patients compared to the nutritional status of conventional hemodialysis patients.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 20
Est. completion date June 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- >18 years of age

- referred to the in-centre nocturnal hemodialysis program

- medically stable

- undergo hemodialysis three to four times per week for a minimum of three hours per week

- able to provide written, informed consent

Exclusion Criteria:

- younger than 18 years old

- have a current diagnosis with palliative status (e.g. cancer) or have active disease

- have had a prolonged hospitalization (>3 weeks) within the previous 3 months

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
No intervention - observational study
No intervention - observational study

Locations

Country Name City State
Canada Alberta Health Services Southern Alberta Renal Program Calgary Alberta

Sponsors (1)

Lead Sponsor Collaborator
University of Calgary

Country where clinical trial is conducted

Canada, 

References & Publications (9)

Chertow GM, Lowrie EG, Wilmore DW, Gonzalez J, Lew NL, Ling J, Leboff MS, Gottlieb MN, Huang W, Zebrowski B, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol. 1995 Jul;6(1):75-81. — View Citation

Demirci C, Ozkahya M, Demirci MS, Asci G, Kose T, Colak T, Duman S, Toz H, Ergin P, Adam SM, Ok E. Effects of three times weekly eight-hour nocturnal hemodialysis on volume and nutritional status. Am J Nephrol. 2013;37(6):559-67. doi: 10.1159/000351182. Epub 2013 May 30. — View Citation

Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C; International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013 Dec;84(6):1096-107. doi: 10.1038/ki.2013.147. Epub 2013 May 22. Review. — View Citation

Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimbürger O, Cederholm T, Stenvinkel P, Carrero JJ. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1720-8. doi: 10.2215/CJN.10261013. Epub 2014 Jul 29. — View Citation

Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001 Dec;38(6):1251-63. — View Citation

Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004 Jun;19(6):1507-19. Epub 2004 Apr 6. — View Citation

Lacson E Jr, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM. Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol. 2010 Feb;5(2):220-6. doi: 10.2215/CJN.06070809. Epub 2009 Dec 3. — View Citation

Lacson E Jr, Xu J, Suri RS, Nesrallah G, Lindsay R, Garg AX, Lester K, Ofsthun N, Lazarus M, Hakim RM. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol. 2012 Apr;23(4):687-95. doi: 10.1681/ASN.2011070674. Epub 2012 Feb 23. — View Citation

Sohrabi Z, Eftekhari MH, Eskandari MH, Rezaeianzadeh A, Sagheb MM. Malnutrition-inflammation score and quality of life in hemodialysis patients: is there any correlation? Nephrourol Mon. 2015 May 23;7(3):e27445. doi: 10.5812/numonthly.7(3)2015.27445. eCollection 2015 May. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Malnutrition Inflammation Score (MIS) A survey/tool that uses both subjective global assessment and objective laboratory measures to evaluate nutritional status. Change from baseline MIS at 6 months will be measured in both groups. Baseline & 6 months No
Secondary Quality of Life KDQOL (SF-36) will be used to measure the quality of life in both groups at baseline and change after 6 months. Baseline & 6 months No
Secondary Dietary Intake 3 day food records will be administered to document changes in dietary intake. Will be measured at baseline and change after 6 months in both groups. Baseline & 6 months No
Secondary Appetite Simplified Nutritional Appetite Questionnaire (SNAQ) will be administered to document changes in appetite. Will be measured at baseline and change after 6 months in both groups. Baseline & 6 months No
Secondary Interdialytic Weight Gain Measurement of fluid weight gain between dialysis sessions; Will be measured in both groups at baseline and after 6 months. Baseline & 6 months No
Secondary Body Mass Index (BMI) Body Mass Index (BMI) will be used to assess change in weight over time. Will be measured in both groups at baseline and after 6 months. Baseline & 6 months No
Secondary Triceps Skinfold Thickness Triceps skinfold thickness will be used to assess changes in muscle and fat mass over time. Will be measured in both groups at baseline and after 6 months. Baseline & 6 months No
Secondary Mid Arm (Muscle) Circumference Mid arm (muscle) circumference will be used to assess changes in muscle and fat mass over time. Will be measured in both groups at baseline and after 6 months. Baseline & 6 months No
Secondary Handgrip Strength Handgrip strength will be used to assess changes in muscle strength over time. Will be measured in both groups at baseline and after 6 months. Baseline & 6 months No
Secondary Bio-electrical Impedance This is completed as one measurement to assess body composition (fat, fluid, muscle). Will be measured at baseline and after 6 months in both groups. Baseline & 6 months No
Secondary Serum Albumin Serum albumin will be measured as part of hemodialysis standard of care. Change in baseline serum albumin will be evaluated at 6 months. Baseline & 6 months No
Secondary C-reactive protein (CRP) C-reactive protein will be measured as part of hemodialysis standard of care. Change in baseline CRP will be evaluated at 6 months. Baseline & 6 months No
Secondary Total iron binding capacity (TIBC) Total iron binding capacity (TIBC) will be measured as part of hemodialysis standard of care. Change in baseline TIBC will be evaluated at 6 months. Baseline & 6 months No
Secondary Phosphate Binders Changes in use and number/dose of phosphate binders will be measured at baseline and after 6 months in both groups. Baseline & 6 months No
See also
  Status Clinical Trial Phase
Completed NCT04103177 - Physical Activity in Haemodialysis Patients: a Feasibility Study N/A
Completed NCT01561118 - DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis N/A
Withdrawn NCT03645720 - The Prognosis of Graft Using Plastic Cannula in Hemodialysis N/A
Active, not recruiting NCT02598635 - Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis Phase 4
Terminated NCT01643733 - Study on Fistuloplasty Using Flow Measurement Guidance N/A
Not yet recruiting NCT03169400 - Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) N/A
Completed NCT02439697 - A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients N/A
Completed NCT02063490 - Nurse-led Intervention to Improve Phosphate Binder Adherence N/A
Completed NCT04106310 - Theranova vs High-flux HD Comparison N/A
Recruiting NCT06056102 - CAR-T Cell Therapy for Desensitization in Kidney Transplantation Phase 1
Completed NCT04698512 - MAgicTouchâ„¢ Intervention Leap for Dialysis Access (MATILDA) Trial
Completed NCT02819011 - OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO Phase 2
Completed NCT02484118 - Hemodialysis Blood Flow and Urea Clearance N/A
Enrolling by invitation NCT01641757 - Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy, Phase 2
Completed NCT03172039 - Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit N/A
Completed NCT03897231 - Prevalence of Non-adherence to Medication Among Patients on Chronic Hemodialysis
Withdrawn NCT03145662 - High Pressure Balloon vs Cutting Balloon N/A
Completed NCT02621918 - The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT01356615 - Low Molecular Weight Heparin for Hemodialysis Anticoagulation N/A
Terminated NCT01033357 - Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access N/A